|
The MRO shall review and take all reasonable and necessary steps to verify the authenticity of all medical records
<br />made available by the tested employee when the source of the confirmed result could have been from legally
<br />prescribed medication. The MRO shall not, however, consider the results of urine or other specimens that are not
<br />obtained or processed in accordance with DOT regulations.
<br />Results. The MRO will use staff under his direct supervision to handle administrative processes for negative test
<br />results including receiving the result from the laboratory, reviewing the paperwork for accuracy, and reporting
<br />of the result to the DER The MRO will personally review at least 5 percent of all CCFs reviewed by their staff, on a'
<br />quarterly basis, not to exceed more than 500 negative results in a quarter.
<br />The MRO staff may make the initial contact with employees having confirmed positive, adulterated, substituted,
<br />and invalid test results, for the purposes of setting up an interview for the MRO. The MRO will personally conduct
<br />the interview with the employee to determine whether there is a legitimate medical explanation for these results.
<br />This interview will be conducted, in most cases, before the Company is notified. If the result is confirmed
<br />positive by the laboratory, and a legitimate medical explanation is established, the MRO will report the result to
<br />the DER as negative. If not, the MRO will report the result to the DER as positive. If the confirmed result is
<br />adulterated or substituted, and a legitimate medical explanation is established, the MRO will report the result to
<br />the DER as cancelled and notify ODAPC, in accordance with Part 40 procedures. if not, the MRO will report the
<br />result to the DER as a refusal to test. If the result is invalid, and an acceptable reason is established, the MRO will
<br />eport the result to the DER as cancelled and the process will stop, unless a negative test result is needed
<br />(e.g,, pre -employment, return -to -duty and follow-up). If an acceptable reason is not established, the MRO will
<br />eport the result to the DER as cancelled and order an immediate recollection under direct observation.
<br />Reports. All drug test results will be reported to the Company DER in a confidential and timely manner.
<br />Before reporting any results, the MRO will have received a copy of the CCF showing where the employee has
<br />signed the form. The time period from collecting the specimen to reporting the verified test result is generally
<br />shorter for negatives than for non -negatives. Non -negatives will not be reported to the DER until all information
<br />required for the employee interview is received and approved by the MRO. The MRO will transmit the
<br />report(s) of verified tests to the Company DER within two days of verification by the MRO. The
<br />Company may use a C/TPA as its intermediary in receiving drug test results. If so, those reports will be handled
<br />n accordance with Part 40 requirements. If the MRO does not use Copy 2 of the CCF for reporting results, the
<br />MRO will maintain a copy of the signed or stamped', report in addition to the signed or stamped and dated Copy
<br />2. If the MRO uses an electronic data file to report negatives, the MRO will maintain a retrievable copy of that
<br />report in a format suitable for inspection and auditing by a DOT representative.
<br />9. Split Specimen Testing
<br />Split Specimen. When the MRO has verified a result as positive, adulterated, or substituted, the MRO will notify
<br />the employee of their right to have the split specimen tested. The employee must notify the MRO within 72 hours of
<br />the result being verified in order to have this testing conducted. If the employee requests that the split specimen
<br />be tested within the 72-hour period, the MRO will ensure that the split specimen is tested. Testing of the split
<br />specimen is only conducted at the request of the employee, and then only after using the MRO as the requesting
<br />agent for the employee. The MRO will select the second laboratory. The MRO will immediately provide written notice
<br />to the laboratory that tested the primary specimen, directing the laboratory to forward the split specimen to the second
<br />HHS-certified laboratory. The MRO will document the date and time of the employee's request.
<br />The Company is
<br />responsible for making sure that the
<br />MRO, first laboratory,
<br />and second laboratory perform the
<br />functions noted in
<br />Part 40 in a timely manner, once
<br />the employee has made
<br />a timely
<br />request for a test of the
<br />split specimen (e.g.,
<br />by establishing appropriate accounts
<br />with laboratories for
<br />testing split
<br />specimens).
<br />The Company must not condition compliance with these requirements on the employee's direct payment to the
<br />MRO or laboratory or the employee's agreement for reimbursement of the costs of testing. For example, if the
<br />Company's asks the employee to pay for some or all of the cost of testing the split specimen, and the employee
<br />s unwilling or unable to do so, the Company must ensure that the test takes place in a timely manner, which
<br />means that the Company will pay for the split testing.
<br />Premium Concrete Services, Inc.- PHMSA DRUG/ALCOHOL PLAN 27
<br />C) NATIONAL GOMPLIANCE MFl�IAGEMENT SERVICE, li IC. (�IGMS) 2�i I (uptla�e 2021J. the NCMS plan is
<br />lho subjod of e roglslnrotl wnyrlght and is prolecled by copyright le�•�s In the U S. anU else��here. All rigiils
<br />eserved
<br />
|